31.08.2023 - EQS-News: PAION AG / Key word(s): Regulatory Approval PAION receives UK MHRA approval of Byfavo (remimazolam) for the induction and maintenance of general anesthesia in adults 31.08.2023 / 14:00 CET/CEST The issuer is solely responsible for the . Seite 1
EQS-News: PAION AG / Key word(s): Regulatory ApprovalPAION receives UK MHRA approval of Byfavo® (remimazolam) for the induction and maintenance of general anesthesia in adults 31.08.2023 / 14:00 CET/CESTThe issuer is solely responsible for the content of this announcement.PAION receives UK MHRA approval of Byfavo® (.
By Andrea Figueras Paion swung to a net loss and posted lower revenue for the first half of the year. The German pharmaceutical company on Wednesday posted a.
EQS-News: PAION AG / Key word: Product Launch
PAION launches Byfavo® in the first European country for General Anesthesia
22.08.2023 / 14:00 CET/CEST
The.
14.08.2023 - EQS-Ad-hoc: PAION AG / Key word(s): Personnel Tilmann Bur succeeds Gregor Siebert as CEO of PAION AG 14-Aug-2023 / 15:14 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News . Seite 1